m-PEG2-Br

CAS No. 54149-17-6

m-PEG2-Br( —— )

Catalog No. M26972 CAS No. 54149-17-6

m-PEG2-Br is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 32 Get Quote
1G 42 Get Quote

Biological Information

  • Product Name
    m-PEG2-Br
  • Note
    Research use only, not for human use.
  • Brief Description
    m-PEG2-Br is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
  • Description
    m-PEG2-Br is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
  • In Vitro
    PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    SUR2-KIR6
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    54149-17-6
  • Formula Weight
    183.045
  • Molecular Formula
    C5H11BrO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COCCOCCBr
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Schwanstecher M, et al. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors. EMBO J. 1998 Oct 1;17(19):5529-35.
molnova catalog
related products
  • Trityl candesartan

    Trityl candesartan is a crucial intermediate used in the synthesis of Candesartan and Candesartan cilexetil, which are angiotensin II receptor antagonists.

  • Kadsurin A

    Kadsurin A has anti-platelet activating factor activities.

  • β-Endorphin, equine ...

    β-Endorphin, equine (TFA) is an endogenous opioid peptide, which binds at high affinity to both μ/δ opioid receptors.